SCHEMBL5780847

SCHEMBL5780847

O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(Br)s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.59
HTT P42858 7/20 0.55
MEN1 O00255 5/20 0.55
KMT2A Q03164 5/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
LMNA P02545 4/20 0.55
MAPT P10636 3/20 0.55
ALOX15 P16050 1/20 0.55
MAPK1 P28482 1/20 0.55
HSD17B10 Q99714 1/20 0.55
TP53 P04637 2/20 0.53
PKM P14618 2/20 0.53
HTR2C P28335 3/20 0.49
DRD2 P14416 2/20 0.49
DRD3 P35462 2/20 0.49
MLNR O43193 2/20 0.49
HTR2A P28223 1/20 0.49
HTR2B P41595 1/20 0.49
TSHR P16473 1/20 0.49
ALDH1A1 P00352 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5727219 0.76 HTR6 (0.58) HTR6MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL10360424 0.74 HTR6 (0.66) HTR6SMN1; SMN2LMNAHTR2CDRD2
SCHEMBL5781306 0.74 HTR6 (1.00) HTR6MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL5727354 0.74 NPC1 (0.48) HTR6HTTMEN1KMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL7014506 0.73 HTR6 (0.64) HTR6SMN1; SMN2LMNAHTR2CDRD2
SCHEMBL1946627 0.72 LMNA (0.77) HTR6SMN1; SMN2LMNAHTR2CDRD2
SCHEMBL6971169 0.72 HTR6 (0.66) HTR6HTTSMN1; SMN2LMNAHTR2C
SCHEMBL13757824 0.71 HTR6 (0.61) HTR6HTR2CDRD2DRD3MLNR
SCHEMBL5780703 0.71 HTR6 (0.54) HTR6SMN1; SMN2LMNATP53HTR2C
SCHEMBL13757819 0.70 PRF1 (0.45) HTR6MEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487801-B1 7-ARYLSULFONAMIDO-2,3,4,5-TETRAHYDRO-1H-BENZO¬D|AZEPINE DERIVATIVES WITH 5-HT6 RECEPTOR AFFINITY FOR THE TREATMENT OF CNS DISORDERS GLAXO GROUP LTD (GB) 2006-04-19 EP claimed
US-20050090496-A1 Sulphonyl compounds with 5-ht6 receptor affinity GLAXO GROUP LIMITED (GB) 2005-04-28 US claimed
US-20050090485-A1 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders GLAXO GROUP LIMITED (GB) 2005-04-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090496-A1 Sulphonyl compounds with 5-ht6 receptor affinity HTR6, HTR4, HTR5A HTR6 1/4885HTT 373/4885MEN1 3904/4885
US-20050090485-A1 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders HTR6, HTR7, HTR2A HTR6 1/4885HTT 655/4885MEN1 2488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.